BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Policy

  European CHMP Adopts Positive Opinion for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide)

  Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Marketing Authorization Application (MAA) for Biktarvy®.

  April 27, 2018

   · 

  3 min read
• Business

  Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer

  Hill-Rom Holdings, Inc. announced that John P. Groetelaars has been appointed president and chief executive officer of the company, effective May 14, 2018.

  April 27, 2018

   · 

  4 min read
• Business

  Foundation Fighting Blindness and Vitrisa Therapeutics Collaborate in Developing Innovative Clinical Trial Designs for Stargardt Disease Treatments

  Results from ProgStar, FFB’s natural history study for people with Stargardt disease, to be used in Vitrisa’s simulation of clinical trial designs for potential therapies

  April 27, 2018

   · 

  4 min read
• Symbility Solutions Has Been Recognized as a Best Workplace in Canada

  Symbility Solutions is thrilled to be recognized as one of 2018’s Best Workplaces™ in Canada.

  April 27, 2018

   · 

  3 min read
• Pharm Country

  Pre-Market Technical Scan on Medical Supplies Equities -- Akers Biosciences, Antares Pharma, Baxter, and Becton, Dickinson and Co.

  allStEquities.com is offering reports on AKER, ATRS, BAX, and BDX.

  April 27, 2018

   · 

  6 min read
• Biotech Bay

  AcelRx receives positive CHMP opinion for DZUVEO™ for management of acute moderate to severe pain in medically monitored settings

  DZUVEO is AcelRx’s second developed sublingual sufentanil-based product to receive positive CHMP opinion, with Zalviso® already approved Resubmission of New Drug Application for DSUVIA™ (known as DZUVEO in Europe) to the FDA in the U.S. is planned for Q2 2018

  April 27, 2018

   · 

  4 min read
• Business

  Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA)

  Invitae Corporation announced that it is launching a new program with Biogen.

  April 27, 2018

   · 

  4 min read
• Business

  Context Therapeutics Co-Founder and CEO Martin Lehr Named Ernst & Young 2018 Entrepreneur of the Year Semifinalist

  Context Therapeutics, LLC, announced that Martin Lehr, Co-founder and CEO of Context Therapeutics, is a semifinalist for Ernst & Young’s (EY) 2018 Entrepreneur of the Year for the Greater Philadelphia region.

  April 27, 2018

   · 

  2 min read
• Business

  Lyndra Inc. and Global Drug Commercialization Center Announce Joint Venture to Develop Lyndra’s Ultra-Long-Acting Oral Dosage Form for Chinese Market

  Announcement comes as Lyndra CEO Amy Schulman’s TEDMED talk is released to the public; Schulman featured as “visionary entrepreneur”

  April 27, 2018

   · 

  5 min read
• Business

  Sanofi: First-quarter 2018 Business EPS up 1.4% at CER

  Sanofi: First-quarter 2018 Business EPS up 1.4% at CER

  April 27, 2018

   · 

  9 min read